发明人郑宇鹏,何建平,张德明. "一种伊布替尼杂质134的合成方法" [P]. 中国发明专利, 专利号 CN 115289083 A, 授权公告日 2021-05-26.
发明人罗永刚,郭海燕,韩伟. "Method for the Synthesis of Ibrutinib Impurity 134" [P]. 中国发明专利, 专利号 CN 115371657 A, 授权公告日 2018-11-01.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质134 in Pharmaceutical Formulations". Environ. Sci. Technol., 2011, 2168, (10), 6486-6501.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质134 as an Impurity". Chemosphere, 2024, 688, 8710-8715.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 134 Using HRMS and NMR". J. Nat. Prod., 2017, 976, 3730-3745.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 伊布替尼杂质134 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2022, 1139, (12), 9467-9475.